
1. parasitol int. 2018 dec;67(6):787-792. doi: 10.1016/j.parint.2018.08.004. epub
2018 aug 14.

characterization plasmodium knowlesi dihydrofolate reductase-thymidylate
synthase sensitivity antifolates.

ittarat w(1), pornthanakasem w(1), mungthin m(2), suwandittakul n(2), leelayoova 
s(2), tarnchompoo b(1), yuthavong y(1), kongkasuriyachai d(1), leartsakulpanich
u(3).

author information: 
(1)national center genetic engineering biotechnology, 113 phahonyothin
road, khlong nueng, khlong luang, pathum thani 12120, thailand.
(2)department parasitology, phramongkutklao college medicine, bangkok
10400, thailand.
(3)national center genetic engineering biotechnology, 113 phahonyothin
road, khlong nueng, khlong luang, pathum thani 12120, thailand. electronic
address: ubolsree@biotec.or.th.

malaria caused infection plasmodium knowlesi result high
parasitemia deaths. therefore, effective prompt treatment necessary to
reduce morbidity mortality. study aims characterize p. knowlesi
dihydrofolate reductase-thymidylate synthase enzyme (pkdhfr-ts) its
sensitivity antifolates. putative pkdhfr gene pcr amplified field
isolates collected southern thailand. molecular analysis showed 11
polymorphisms dhfr domain bifunctional dhfr-ts gene. these, 1
polymorphism non-synonymous substitution (r34l) previously been
reported associated antifolate resistance. recombinant pkdhfr-ts
enzyme found sensitive standard antifolates-pyrimethamine and
cycloguanil-as well p218, registered candidate drug currently first human
clinical trial. results suggest antifolates class compounds be
effective p. knowlesi infection.

copyright Â© 2018 elsevier b.v. rights reserved.

doi: 10.1016/j.parint.2018.08.004 
pmid: 30114522  [indexed medline]

